Table of Content

1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Pricing Analysis
4.4. Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.3. Asia-Pacific
4.4.3.1. China
4.4.3.2. Japan
4.4.3.3. India
4.4.4. Latin America
4.4.5. Middle East
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Buyers
4.5.2. Bargaining Power of Suppliers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition

5. Sequencing Kits & Reagents Market Assessment?by Type
5.1. Overview
5.2. Nucleic Acid Extraction & Amplification Kits & Reagents
5.3. Sequencing Kits & Reagents
5.4. Library Preparation Kits & Reagents
5.5. Control Kits & Reagents
5.6. Other Kits & Reagents

6. Sequencing Kits & Reagents Market Assessment?by Technology
6.1. Overview
6.2. Next-generation Sequencing
6.3. Sanger Sequencing
6.4. Third & Fourth-generation Sequencing
6.5. Other Sequencing Technologies

7. Sequencing Reagents & Kits Market Assessment?by Application
7.1. Overview
7.2. Research Applications
7.2.1. Drug Discovery
7.2.2. Agricultural & Animal Research
7.2.3. Other Research Applications
7.3. Clinical Applications
7.3.1. Oncology
7.3.2. Reproductive Health
7.3.3. Infectious Diseases
7.3.4. Other Clinical Applications

8. Sequencing Reagents & Kits Market Assessment?by End User
8.1. Overview
8.2. Pharmaceutical & Biotechnology Companies
8.3. Hospitals & Diagnostic Laboratories
8.4. Academic & Research Institutes
8.5. Other End Users

9. Sequencing Kits & Reagents Market Assessment? by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa

10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis (2022)
10.5.1. Illumina, Inc. (U.S.)
10.5.2. Thermo Fisher Scientific Inc. (U.S.)
10.5.3. Beijing Genomics Institute (BGI) (China)
10.5.4. QIAGEN N.V. (Netherlands)
10.5.5. Agilent Technologies, Inc. (U.S.)

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. Illumina, Inc.
11.2. Thermo Fisher Scientific Inc.
11.3. Beijing Genomics Institute (BGI)
11.4. QIAGEN N.V.
11.5. Agilent Technologies, Inc.
11.6. F. Hoffmann-La Roche Ltd
11.7. PerkinElmer, Inc. (Renamed as Revvity)
11.8. Pacific Biosciences of California, Inc.
11.9. Danaher Corporation
11.10. Bio-Rad Laboratories, Inc.
11.11. Oxford Nanopore Technologies Plc.
11.12. 10X Genomics, Inc.
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix
12.1. Available Customization
12.2. Related Reports



List of Figures

Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Sequencing Kits & Reagents Market, by Type, 2023 VS. 2030 (USD Million)
Figure 8 Global Sequencing Kits & Reagents Market, by Technology, 2023 Vs.2030 (USD Million)
Figure 9 Global Sequencing Kits & Reagents Market, by Application, 2023 VS. 2030 (USD Million)
Figure 10 Global Sequencing Kits & Reagents Market, by End User, 2023 VS. 2030 (USD Million)
Figure 11 Global Sequencing Kits & Reagents Market, by Geography, 2023 VS. 2030 (USD Million)
Figure 12 Global Sequencing Kits & Reagents Market: Impact Analysis of Market Drivers, Restraints, Opportunities, And Challenges (2023–2030)
Figure 13 Number of Cancer Cases, by Region, 2020
Figure 14 Genome Sequencing Costs, 2010–2021 (USD/Genome)
Figure 15 Pharmaceutical R&D Expenditures in The U.S., Europe, And China, 2010 VS. 2019 VS. 2020 (USD Million)
Figure 16 Global Pharmaceutical R&D Expenditure, 2014–2028 (USD Billion)
Figure 17 Percentage of Approved Personalized Medicines: Cancer VS. Rare Diseases VS. Other Diseases, 2022
Figure 18 USFDA Regulatory Pathways for IVD Kits
Figure 19 Eu Regulatory Pathway - IVDR 2017/746
Figure 20 China: Medical Device Classification and Premarket Requirements for IVD Products
Figure 21 Porter’s Five Forces Analysis
Figure 22 Global Sequencing Kits & Reagents Market, by Type, 2023 Vs 2030 (USD Million)
Figure 23 Global Sequencing Kits & Reagents Market, by Technology, 2023 VS. 2030 (USD Million)
Figure 24 Global Sequencing Kits & Reagents Market, by Application, 2023 VS. 2030 (USD Million)
Figure 25 U.S.: New Molecular Entity (Nme) Approvals
Figure 26 Estimated Number of New Cancer Cases (In Million)
Figure 27 Global Sequencing Kits & Reagents Market, by End User, 2023 VS. 2030 (USD Million)
Figure 28 Global Pharmaceutical R&D Spending, 2014–2026 (USD Billion)
Figure 29 Global Sequencing Kits & Reagents Market, by Geography, 2023 VS. 2030 (USD Million)
Figure 30 North America: Sequencing Kits & Reagents Market Snapshot
Figure 31 U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 32 Europe: Pharmaceutical Industry R&D Expenditure (2000–2021)
Figure 33 Europe: Sequencing Kits & Reagents Market Snapshot
Figure 34 Italy: Number of Biotechnology Firms, 2010-2021
Figure 35 Rest of Europe: Pharmaceutical R&D Expenditure, 2020
Figure 36 Asia-Pacific: Sequencing Kits & Reagents Market Snapshot
Figure 37 Latin America: Sequencing Kits & Reagents Market Snapshot
Figure 38 Key Growth Strategies Adopted by Leading Players, 2020– 2023
Figure 39 Sequencing Kits & Reagents Market: Competitive Benchmarking by Technology
Figure 40 Sequencing Kits & Reagents Market: Competitive Benchmarking, by Region
Figure 41 Competitive Dashboard: Sequencing Kits & Reagents Market
Figure 42 Global Sequencing Kits & Reagents Market Share Analysis, by Key Players, 2022 (%)
Figure 43 Illumina, Inc.: Financial Overview (2022)
Figure 44 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 45 Beijing Genomics Institute (BGI): Financial Overview (2022)
Figure 46 Qiagen N.V.: Financial Overview (2022)
Figure 47 Agilent Technologies, Inc.: Financial Overview (2022)
Figure 48 F. Hoffmann-La Roche Ltd: Financial Overview (2022)
Figure 49 Perkinelmer, Inc.: Financial Overview (2022)
Figure 50 Pacific Biosciences of California, Inc.: Financial Overview (2022)
Figure 51 Danaher Corporation: Financial Overview (2022)
Figure 52 Bio-Rad Laboratories: Financial Overview (2022)
Figure 53 Oxford Nanopore Technologies Plc.: Financial Overview (2022)
Figure 54 10X Genomics, Inc.: Financial Overview (2022)